News Center

Home page

Peak Report

News reports

Pro 2013-021 (Jianfeng Group Corporate Bond Listing Announcement)-5

Release time:

2020-08-05

Section VII Description of Bond Follow-up Rating Arrangement

According to the relevant regulations of the regulatory authorities and the relevant requirements of United Rating on follow-up rating, United Rating will conduct a regular follow-up rating on this bond within months after the annual report of the issuer is announced during the effective duration of this bond, and during the term of this bond, no regular tracking rating will be carried out according to the relevant circumstances.

Issuers should provide relevant financial reports and other relevant information as required by the Joint Rating Tracking Rating Information List. The issuer shall promptly notify the joint rating and provide relevant information in the event of major changes or major events that may have a significant impact on the credit rating.

Joint rating will pay close attention to the operation and management status and relevant information of the issuer. If major changes are found in the relevant elements of the issuer or this bond, or the existence or occurrence of major events that may have a greater impact on the credit rating, Joint rating will implement the relevant situation and assess its impact on the credit rating in a timely manner, to confirm or adjust the credit rating of the bonds.

If the issuer is unable to provide the relevant information and circumstances required for the above-mentioned tracking rating in a timely manner, Joint Rating will analyze and adjust the credit rating according to the relevant circumstances, and if necessary, the credit rating may be released temporarily until the issuer provides the relevant information.

tracking rating results will be published on the joint credit rating website ( www.lianheccreditrating.com.cn ), Shanghai Stock Exchange website (www.sse.com.cn ) and Juchao Information Network (www.cninfo.com.cn ) and submitted to issuers, regulatory authorities, trading institutions, etc.

Section VIII Bond Guarantee Basic Information

This corporate bond is guaranteed by Tasly Group with full unconditional and irrevocable joint and several liability guarantee.

Basic Information of 1. Guarantor

Overview of (I) Guarantor

Company Name:	Tianjin Tianshili Group Co., Ltd.
Company Domicile:	Tianjin Beichen Science and Technology Park
Legal Representative:	Yan Xijun
Registered Capital:	23,784.38 million Yuan
Paid-in Capital:	23,784.38 .13 million Yuan
Date of Establishment:	2000 # December August 30
Business Scope:	Foreign Investment and Holding; Planting of natural plant drugs and related processing and separation; organize subordinate enterprises to carry out product production, scientific research, sales, import and export business; wholesale and retail of all kinds of goods and materials; technology development, consultation, service, transfer of biotechnology (excluding drug production and sales) and products; lease of self-owned equipment and houses; all kinds of economic information consultation; export business of technology developed and scientific research products produced by the enterprise; import of technology, raw and auxiliary materials, mechanical equipment, instruments and spare parts required by the enterprise for scientific research and production; The enterprise's feed processing and "three to one supplement" business; Mining development and operation; Production of raw materials (fexofenadine hydrochloride, right zopiclone); Internet information services (information services other than news, publishing, education, medical devices and electronic announcements, business coverage: tianjin)

(II) Guarantor's Main Financial Data and Indicators for the Last Two Years

According to Tianshili Group 2012 Year and 2011 Year Consolidated Financial Statements, the main financial indicators (consolidated caliber) are as follows (among them, 2012 financial statements were audited by Tianjian Certified Public Accountants (Special General Partnership) and issued an unqualified audit report of Tianjian Audit [2013]1490 . 2011 financial statements were audited by Tianjian Certified Public Accountants (Special General Partnership), and issued an unqualified audit report of Tianjian Audit [2012]1259 ):

288 ################# Year Operating Income (RMB 10,000) 17.43 / total assets

Project	2012 June 31	2011 # June
# Total 205 Assets (RMB 10,000)	1,086,359.73	1,041,815.88
# Total 222 Liabilities (RMB 10,000)	635,002.04	634,383.72
Total Owner's Equity (RMB 10,000)	451,357.69	407,432.16
belongs to the owner's equity of the parent company (RMB 10,000)	192,319.11	169,366.60
Asset-liability Ratio ()	58.45	60.89 ###################
1.36	Quick Ratio (Times)	1.10
1.15	Project	2012
2011 Year		996,963.81
927,977.29	Total Profit (RMB 10,000)	95,489.91
86,209.96	Net Profit (RMB 10,000)	74,862.82
66,824.87	Net Profit Attributed to Owners of Parent Company	36,309.41
24,656.81	Return on Net Assets (	)
17.01	The calculation method of the above financial indicators is as follows:	asset-liability ratio = total liabilities

current ratio =

current assets

/ current liabilities

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页